Rep. Jay Obernolte, representing California’s 23rd district in the U.S. Congress, has been active on social media discussing recent legislative developments and his new role in a congressional subcommittee. His posts cover topics ranging from the opioid crisis to border security and technological innovation.
On February 8, 2025, Rep. Obernolte announced the passage of the HALT Fentanyl Act (H.R.27) in the House of Representatives. As an original cosponsor, he expressed pride in this legislative achievement, emphasizing its importance in addressing the opioid crisis: “As an original cosponsor, I am proud to announce that the HALT Fentanyl Act (H.R.27) has successfully passed the House, marking a significant step in our fight against the opioid crisis.”
The following day, February 9, 2025, Rep. Obernolte voiced support for President Trump’s Remain in Mexico policy by backing legislation to reinstate it. He stated: “President Trump’s Remain in Mexico policy is a critical tool for securing our border and reducing illegal immigration.” This reflects his stance on border security measures.
Later that day, he shared news about his appointment as Chairman of the Research and Technology Subcommittee on the House Science, Space, and Technology Committee. In his tweet he noted: “This week I was honored to be named the Chairman of the Research and Technology Subcommittee on the House Science, Space, and Technology Committee.” This highlights his commitment to advancing policies supporting innovation.
